Once-Weekly vs Twice-Weekly Bortezomib for Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
Blood Cancer J 2024 Mar 22;14(1)52, FW Hoff, R Banerjee, AM Khan, G McCaughan, B Wang, X Wang, J Roose, LD Anderson, AJ Cowan, SV Rajkumar, G KaurFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.